Thus, the region between -112 and -48 bp (containing AP1-2/SP1-2 binding sites) seemed to be responsible for AP1/SP1-dependent transactivation with Hcy treatment or DNA methylation in HCC. Here, SP1 is linked to hepatocellular carcinoma.